Clinical Trial Update: A Study of Low and Standard-dose Ticagrelor After Intervention for ACS Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating low- and standard-dose ticagrelor after intervention in acute coronary syndrome patients undergoing coronary stent implantation. Stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Stent Implantation
• Coronary Syndrome

Drugs mentioned

• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Shanghai Tong Ren Hospital | Conditions: Acute Coronary Syndrome, Coronary Stent Implantation | Phase 4 | Status: UNKNOWN